There was a mistake in Table 2 as published. The data for the two surgical instrument rows, “Coblation” and “Microdebrider,” were inadvertently interchanged. The data currently shown under “Coblation” should appear under “Microdebrider,” and vice versa. The corrected Table 2 appears below.
Table 2.
Comparisons of demographic and clinical characteristics between training set and validation set.
| Variables | Training set (n = 155) | Validation set (n = 67) | P |
|---|---|---|---|
| Age, month | 63.00 [51.00–79.50] | 68.00 [49.50–81.00] | 0.735 |
| Sex | 0.279 | ||
| Male, n (%) | 81 (52.26%) | 41 (61.19%) | |
| Female, n (%) | 74 (47.74%) | 26 (38.81%) | |
| BMI, kg/m2 | 15.80 [14.63–17.36] | 15.62 [14.43–17.36] | 0.660 |
| A/N | 0.78 [0.70–0.88] | 0.79 [0.72–0.89] | 0.626 |
| Adenoidectomy instrument | 1.000 | ||
| Coblation, n (%) | 67 (43.23%) | 29 (43.28%) | |
| Microdebrider, n (%) | 88 (56.77%) | 38 (56.72%) | |
| Grommet insertion | 0.356 | ||
| No, n (%) | 144 (92.90%) | 59 (88.06%) | |
| Yes, n (%) | 11 (7.10%) | 8 (11.94%) | |
| Tonsillotomy | 0.801 | ||
| No, n (%) | 131 (84.52%) | 55 (82.09%) | |
| Yes, n (%) | 24 (15.48%) | 12 (17.91%) | |
| Tonsillectomy | 0.349 | ||
| No, n (%) | 85 (54.84%) | 42 (62.69%) | |
| Yes, n (%) | 70 (45.16%) | 25 (37.31%) | |
| Endoscopic sinus surgery | 0.302 | ||
| No, n (%) | 155 (100.00%) | 66 (98.51%) | |
| Yes, n (%) | 0 (0.00%) | 1 (1.49%) | |
| OME | 0.923 | ||
| No, n (%) | 132 (85.16%) | 56 (83.58%) | |
| Yes, n (%) | 23 (14.84%) | 11 (16.42%) | |
| AR | 0.506 | ||
| No, n (%) | 25 (16.13%) | 14 (20.90%) | |
| Yes, n (%) | 130 (83.87%) | 53 (79.10%) | |
| CRS | 0.449 | ||
| No, n (%) | 116 (74.84%) | 54 (80.60%) | |
| Yes, n (%) | 39 (25.16%) | 13 (19.40%) | |
| Asthma | 0.789 | ||
| No, n (%) | 140 (90.32%) | 59 (88.06%) | |
| Yes, n (%) | 15 (9.68%) | 8 (11.94%) | |
| Perioperative antibiotics | 0.445 | ||
| No, n (%) | 57 (36.77%) | 29 (43.28%) | |
| Yes, n (%) | 98 (63.23%) | 38 (56.72%) | |
| Postoperative rhGH | 0.555 | ||
| No, n (%) | 152 (98.06%) | 67 (100.00%) | |
| Yes, n (%) | 3 (1.94%) | 0 (0.00%) | |
| Postoperative GnRHa | 1.000 | ||
| No, n (%) | 153 (98.71%) | 66 (98.51%) | |
| Yes, n (%) | 2 (1.29%) | 1 (1.49%) |
BMI, body mass index; A/N, the adenoid-to-nasopharyngeal ratio; OME, otitis media with effusion; AR, allergic rhinitis; CRS, chronic sinusitis; rhGH, recombinant human growth hormone; GnRHa, gonadotropin-releasing hormone analog.
The original version of this article has been updated.
Footnotes
Edited and Reviewed by: Hong He, School of Stomatology, Wuhan University, China
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.